BioSpace News Archive

Supermarket Company’s Pharmacies Offering Opioid Overdose-Reversing Drug Naloxone and Hosting Drug Take-Back Event at Leisure World in Seal Beach

Eloxx Pharmaceuticals, Inc. (“Eloxx”), (ELX:OTCQ), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that two abstracts, including one Later Breaker, for its lead candidate, ELX-02 will be presented at the 41stEuropean Cystic Fibrosis Conference taking place on June 6-9, 2018 in Belgrade, Serbia.

Women need magnesium to help combat common health conditions like premenstrual syndrome (PMS), hormonal migraines, anxiety and depression, says author of Super Woman RX Dr. Tasneem Bhatia.

Independence Health Group announced a partnership to launch a newly branded, patient-centered technology and communications platform that seeks to improve the overall efficiency and experience of the care delivery process between providers and patients.

ANSYS is transforming how the aerospace and defense, biotech and automotive industries manufacture metal parts thanks to its new solutions for metal additive manufacturing.

The Medicines Company will host a conference call and audio webcast on Wednesday, April 25, 2018, at 8:30 a.m., Eastern Time, to discuss first-quarter 2018 financial results and operational developments.

FirstLight Home Care is congratulating Brian Anderson, who was recognized by the Franchise Business Review as a 2018 Rockstar Franchisee.

Gilla Kaplan, Ph.D., retiring from Board of Directors after 20 years of service US health insurance expert Patricia Hemingway Hall elected to Board of Directors Juno Therapeutics co-founder and former CEO Hans Bishop elected to Board of Directors

Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology and software solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report first quarter 2018 financial results before the open of U.S. financial markets on Tuesday, May 1, 2018

Tocagen eligible to receive up to $127 million in upfront payment, development and commercial milestones, plus additional double-digit tiered sales royalties; Upfront and near-term development milestones payments total up to $20 million